Drugs News and Research

RSS

Gut microbiome appears to play key role in heart transplant outcomes

In a new study, researchers at the University of Maryland School of Medicine have found that the gut microbiome appears to play a key role in how well the body accepts a transplanted heart. The scientists found a causal relationship between the presence of certain microbes and transplant outcome.

4 Oct 2018

Common herbicide compound could help fight hospital-acquired fungal infections

A chemical compound found in common herbicides could help fight hospital-acquired human fungal pathogenic infections, which claim an estimated two million lives per year.

4 Oct 2018

UConn chemists develop new antibiotic that can find and kill tuberculosis bacteria

Tuberculosis is a sneaky disease. The bacteria hide from antibiotics inside the very immune cells that are supposed to kill them, making treatment long and difficult. But in the November issue of ACS Infectious Diseases, UConn chemists report a new antibiotic that can find and kill tuberculosis bacteria where they hide.

4 Oct 2018

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.

4 Oct 2018

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study showed treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in people at high risk of serious complications from the flu, which includes adults 65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.

4 Oct 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

Two-pronged approach represents potential strategy for targeting latent reservoir of HIV

With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.

4 Oct 2018

Stevens researchers develop new class of molecules for breast cancer treatment

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.

4 Oct 2018

New ReFRAME drug repurposing collection offers hope for treating major diseases

Each year, millions of people worldwide suffer from potentially fatal infectious diseases that often leave survivors facing a lifetime of related health problems. But what if drugs against such diseases already existed but nobody knew it?

4 Oct 2018

Newly discovered compounds may explain whole grain health benefits

Scientists have discovered new compounds that may explain whole grain health benefits, reports a new study led by the University of Eastern Finland.

3 Oct 2018

Eagle Pharmaceuticals and USAMRICD signs agreement to assess neuroprotective effects of RYANODEX

Eagle Pharmaceuticals, Inc. today announced that it has entered into an agreement with the United States Army Medical Research Institute of Chemical Defense, the nation's leading science and technology laboratory in the area of medical chemical countermeasures research and development, to conduct a study to evaluate the neuroprotective effects of RYANODEX.

3 Oct 2018

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

Therapure Biomanufacturing, an integrated contract development and manufacturing organization and a division of Therapure Biopharma Inc., today announced approval for the manufacturing of Insmed Incorporated's ARIKAYCE® at its Mississauga facility by the U.S. Food and Drug Administration.

3 Oct 2018

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

It took more than 10 minutes for paramedics to arrive after a housekeeper found a man collapsed on the floor of a bathroom in a Boston Veteran Affairs building.

3 Oct 2018

Cancer Research UK congratulates scientists for Nobel Prize-winning discoveries

The Nobel Prize-winning discoveries made by these scientists has revolutionized not only our understanding of the immune system and cancer, but also the field of cancer treatment.

3 Oct 2018

Molecule research reveals potential drug target for treating stroke patients

In an extension of research published a month ago in Nature Methods, a novel hybrid approach performed by researchers from Clemson University's department of physics and astronomy and Stony Brook University has revealed a 3-D structure of a protein fragment that could serve as a drug target in treating stroke patients.

3 Oct 2018

New search technique efficiently identifies antibiotic compounds

If you're looking for a needle in a haystack, it's best to know what hay looks like. An international team of researchers has applied this idea to the search for new pharmaceuticals, developing a technique that reduces the chances of simply rediscovering known compounds.

3 Oct 2018

Miniature magnetic swimming devices could deliver drugs to specific areas of body

Scientists have created miniature magnetic swimming devices - which mimic the appearance of sperm cells - that could revolutionize disease treatment by swimming drugs to specific areas of the body.

3 Oct 2018

New way of using natural killer cells makes immunotherapy viable to more patients

Immunotherapy is making headlines for saving the lives of hundreds of cancer patients including former President Jimmy Carter. But many of these therapies, only work for a small portion of people who have a specific molecule called PDL1 in their cancer makeup.

3 Oct 2018

Study identifies camelid nanobodies capable of blocking EGF in cancer cells

The natural world often provides the answer to unsolved medical problems. On this occasion, the solution to a challenge posed by cancer has come about from the immune system of camelids.

3 Oct 2018

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

SCIENTISTS fighting cancer have carried out the first successful trial of the effects of the antibiotic Doxycycline on cancer reoccurrence in patients after surgery.

3 Oct 2018

Drugs News and Research

Gut microbiome appears to play key role in heart transplant outcomes

Common herbicide compound could help fight hospital-acquired fungal infections

UConn chemists develop new antibiotic that can find and kill tuberculosis bacteria

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Two-pronged approach represents potential strategy for targeting latent reservoir of HIV

Stevens researchers develop new class of molecules for breast cancer treatment

New ReFRAME drug repurposing collection offers hope for treating major diseases

Newly discovered compounds may explain whole grain health benefits

Eagle Pharmaceuticals and USAMRICD signs agreement to assess neuroprotective effects of RYANODEX

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

Cancer Research UK congratulates scientists for Nobel Prize-winning discoveries

Molecule research reveals potential drug target for treating stroke patients

New search technique efficiently identifies antibiotic compounds

Miniature magnetic swimming devices could deliver drugs to specific areas of body

New way of using natural killer cells makes immunotherapy viable to more patients

Study identifies camelid nanobodies capable of blocking EGF in cancer cells

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News